A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
Functional validation of the Plasmodium falciparum K13 C580Y mutation in recently collected Ethiopian isolates.
Mukherjee A, Assefa AB, Turlo CV, Needham LC, Shoue D, Qahash T, Belachew M, Tadesse D, Kassie E, Berihun M, Brhane BG, Parr JB, Ferdig MT, MAREE Consortium · Antimicrob Agents Chemother (2026)
Ethiopia · DOI: 10.1128/aac.00495-26
Recent genomic investigation in Ethiopia identified the first detection of the Plasmodium falciparum Kelch13 (K13) C580Y substitution in the Horn of Africa. To assess its functional impact, we introduced C580Y into two recently collected Ethiopian clinical isolates using CRISPR-Cas9 genome editing. Ring-stage survival assays showed significantly elevated in vitro dihydroartemisinin survival in edited parasites relative to isogenic controls, demonstrating that C580Y confers artemisinin tolerance in contemporary Ethiopian parasite genetic backgrounds.
Lodging is a major constraint in maize production, causing significant yield losses, reduced grain quality, and harvesting inefficiencies, thereby posing a serious challenge to global food security and climate-resilient agriculture. This review synthesizes current knowledge on the genetic, physiological, and agronomic determinants of maize lodging resistance and evaluates holistic strategies for improving tolerance to lodging stress. Recent advances in quantitative trait locus (QTL) mapping, genome-wide association studies (GWAS), functional gene characterization, genome editing, high-throughput phenotyping, and precision agronomy have provided powerful tools to enhance stalk biomechanics, root anchorage, and adaptive plant architecture. Integrating genomic discovery with advanced phenomics and optimized agronomic management offers a scalable framework for accelerating the development of high-yielding, lodging-resilient maize cultivars. However, critical gaps remain in understanding the genetic coordination between stalk strength and root system architecture, integrating multi-omics approaches to unravel regulatory networks, validating genome-editing interventions across diverse agro-ecologies, and developing environment-responsive predictive breeding models and cost-effective phenotyping tools, particularly for stress-prone regions. Addressing these challenges through coordinated multi-environment trials and integrative molecular-agronomic strategies will facilitate the translation of genomic discoveries into climate-resilient, high-performing maize cultivars. By consolidating molecular insights with applied breeding and management practices, this review provides a comprehensive framework that guides researchers in designing genome-informed and field-validated approaches to improve maize resistance to lodging stress and support sustainable crop production systems.
Mapping Wastewater Pathogens and Their Associated Environmental and Public Health Risk Factors: A Systematic Review and Meta-Analysis.
Mugisha JC, Daba TM, Ndahimana R, Musabyimana JP, Gashegu M, Green CA, Muvunyi CM, Mutesa L · Int J Infect Dis (2026)
Rwanda · DOI: 10.1016/j.ijid.2026.109097
Wastewater-based epidemiology (WBE) has emerged as a critical tool for public health surveillance, yet its application across diverse pathogens and geographical settings remains inconsistent. This systematic review synthesizes global evidence on wastewater surveillance to identify associated risk factors.
Following PRISMA 2020 guidelines (PROSPERO: CRD420261297382), a systematic search was conducted across PubMed, Scopus, Google Scholar, and Web of Science for studies published between 2000 and 2025.
Thirty-nine peer-reviewed studies were included. The evidence base is geographically skewed toward the European Region (48.7%) and the Americas (23.1%), with significant underrepresentation in LMICs. Viruses were the primary biological target (89.7%), followed by bacteria (7.7%) and parasites (2.6%). A proportion meta-analysis of 31 eligible studies demonstrated a pooled wastewater pathogen detection prevalence of 62% (95% CI: 47.5-74.6%), with the European Region yielding the highest regional estimate (73%) and the African Region the lowest (8.3%). Conventional PCR and sequencing methods showed higher pooled detection rates (92.4% and 90.1%, respectively) than RT-qPCR (47.9%).
WBE provides a robust early-warning system indicating a need for broader pathogen diversity, incorporating bacterial and parasitic surveillance and expansion into rural and resource-limited regions.
Association of Cyp2c19 Genotype with Variability in Clopidogrel Response in Coronary Patients.
Yacoub F, Chouchene S, Foddha H, Abderahmene A, Dabboubi R, Raddaoui H, Razzek M, Aissi RE, Elaissi R, Gaaloul M, Messaoud T, Omezzine A, Hassine M · Indian J Hematol Blood Transfus (2026)
Tunisia · DOI: 10.1007/s12288-025-02200-x
The variability of clopidogrel response is due to many factors including polymorphisms affecting CYP2C19. This study aims to assess the impact of the CYP2C19*2(681G > A), CYP2C19*3(636G > A) and CYP2C19*17(-806 C > T) polymorphisms on platelet response to clopidogrel in patients with coronary artery disease. This is a cross-sectional study led on patients treated with clopidogrel (75 mg/day for at least seven days). Platelet reactivity was assessed by the VerifyNow® P2Y12 test and high on treatment platelet reactivity was defined by a PRU ≥ 208. The genotyping of CYP2C19 polymorphisms was performed by PCR- RFLP. The study involved 115 coronary patients with a mean age of 58 ± 10 years. The VerifyNow®P2Y12 test showed that 27.8% were resistant to clopidogrel. The genetic study showed that CYP2C19*2(681G > A) is significantly associated with biological resistance to clopidogrel (G vs. A, OR = 4.713 [95% CI: 1.738-12.780]; p = 0.002), while CYP2C19*17(-806 C > T) is a protective factor against clopidogrel non-responsiveness (C vs. T, OR = 0.413 [95% CI: 0.174-0.981]; p = 0.02). By classifying patients into extensive (*1/*1: 52%), intermediate (*1/*2: 16%) and ultra-rapid metabolizers (*1/*17;*17/*17: 32%), we found that the type of metabolizer had a significant impact on clopidogrel response (p = 0.001). CYP2C19*2 (681G > A) is significantly associated with biological resistance to clopidogrel while CYP2C19*17(-806 C > T) is a protective factor against clopidogrel non-responsiveness.
Global Diffusion of IncC Plasmid Harboring blaNDM-1in the High-Risk Escherichia coli ST131 Clone.
Bouhalouene K, Raddaoui A, Chebbi Y, Achour W · J Appl Microbiol (2026)
Tunisia · DOI: 10.1093/jambio/lxag229
The global expansion of quinolone-resistant Escherichia coli (QR-EC) is increasingly associated with β-lactam resistance and mobile genetic elements that facilitate resistance dissemination. This study investigated the molecular mechanisms underlying fluoroquinolone and β-lactam resistance in clinical QR-EC isolates and explored the plasmid type associated.
A total of 123 non-duplicate QR-EC clinical isolates responsible mainly for gastrointestinal colonization were collected between 2019 and 2021. Plasmid-mediated quinolone resistance (PMQR), extended-spectrum β-lactamase (ESBL), and carbapenemase genes were screened by PCR. Mutations in the quinolone resistance-determining regions (QRDR) of gyrA and parC were analyzed using sequencing and mismatch amplification mutation assay PCR (MAMA-PCR). Selected isolates underwent multilocus sequence typing (MLST). Whole-genome sequencing (WGS) of a representative extensively drug-resistant strain carrying multiple quinolone resistance determinants, ESBL genes, and carbapenemase genes, was performed. PMQR genes were prevalent among QR-EC, dominated by aac(6')-Ib-cr (60.9% of isolates). ESBL genes were identified in 93.5% of isolates, predominantly blaCTX-M (95.7%). Among ertapenem-resistant isolates (QCR-EC) (n = 18), blaNDM-1 and blaOXA-48 were detected in 13 and 11 isolates, respectively. QRDR mutations were highly frequent, particularly gyrA83 (98.4%) and parC80 (30.9%). Major QCR-EC genotypes belonged to sequence types ST167 (n = 2), ST1196, ST469, and ST410. High-risk E. coli ST131 clone harboring IncC plasmid encoding blaNDM-1 was described for the first time in Africa, following its emergence, in two continents, Asia and America. Despite the very rare description of these strains worldwide, their description in three continents sign their global diffusion.
This finding highlights the ongoing spread of carbapenem resistance and underscores the urgent need for strengthened genomic surveillance.
Unlocking the molecular engineering of Geobacillus glycoside hydrolases as a source of industrial biocatalysts.
Bendjaballah H, Gomri MA · Biotechnol Lett (2026)
Algeria · DOI: 10.1007/s10529-026-03781-x
This review examines Geobacillus sensu stricto as a source of thermostable glycoside hydrolases (GH) for biomass conversion, food processing, and enzyme engineering. Recent peer-reviewed literature was assessed with emphasis on taxonomy, genome-based Carbohydrate-Active Enzymes (CAZyme) prediction, biochemical validation, structural data, and engineering case studies. Taxonomic boundaries were interpreted using current Anoxybacillaceae frameworks, with Parageobacillus treated as a related comparator rather than as Geobacillus. The strongest evidence supports GH13 alpha-amylases, xylan-active systems, beta-xylosidases, and selected accessory enzymes. Recent studies also show that genome mining must be coupled with enzymatic assays and product profiling because CAZyme annotation alone does not prove industrial function. Molecular engineering has improved relevant traits, including the longer thermal half-life of engineered G. stearothermophilus alpha-amylase variants, the increased catalytic efficiency of oligo-alpha-1,6-glucosidase variants, and improved AmyS expression in Bacillus subtilis. Geobacillus glycoside hydrolases are best interpreted as process-specific, engineerable biocatalytic templates. Their translation requires reliable taxonomy, functional validation, structural interpretation, scalable expression and testing on realistic substrates. This synthesis also recognises current limitations: many predicted CAZymes still lack biochemical validation, complete cellulolytic systems remain less mature than xylan- and starch-active systems, and scale-up data remain scarce.
Genome-wide identification, characterization, evolutionary analysis, and expression profiling of the FCS-like zinc finger (FLZ) gene family in soybean (Glycine max L.) under abiotic stresses.
Abdullah MI, Lamlom SF, Emwas AH, Jaremko M, Abdelsalam NR · Sci Rep (2026)
Egypt · DOI: 10.1038/s41598-026-67801-6
Drought and salinity limit soybean yield. Despite their role in the SnRK1 energy-sensing complex, a systematic study of FCS-Like Zinc Finger (FLZ) proteins in soybean has not been reported. We performed a genome-wide identification of the GmFLZ gene family, identifying 40 members distributed across 18 of the 20 soybean chromosomes. Phylogenetic analysis of 87 FLZ proteins from Glycine max, Arabidopsis thaliana, and Oryza sativa revealed four major evolutionary clades, suggesting that diversification predates the separation of monocots and dicots. Structural analysis identified ten conserved motifs, with Motifs 1 and 2 present in all family members. Gene duplication analysis identified 304 paralogous pairs, most arising from segmental duplication. Ka/Ks analysis indicated localized positive selection in six gene pairs and purifying selection in 97.9% of pairs. Tissue-specific expression profiling across nine tissues showed that GmFLZ5, GmFLZ15, GmFLZ25, and GmFLZ34 had the highest expression levels detected across the GmFLZ family, with GmFLZ5 the most highly expressed member in leaves, nodules, and stem and showing moderate expression in pod, root, and root hairs, whereas GmFLZ18, GmFLZ23, and GmFLZ37 showed root-preferential expression. RT-qPCR validation under drought (20% PEG-6000) and salt (200 mM NaCl) treatments in the Giza 5 cultivar showed that 36 and 34 of the 40 GmFLZ genes, respectively, exhibited at least a two-fold change in expression, with GmFLZ21 and GmFLZ35 among the most strongly induced under salt stress. These findings provide an evolutionary and functional framework for the GmFLZ family and identify candidate genes for future functional studies in soybean stress tolerance.
Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases.
Marei HE, Pozzoli G, Caratelli S, Cenciarelli C · Stem Cell Res Ther (2026)
Egypt · DOI: 10.1186/s13287-026-05266-0
Chimeric antigen receptor (CAR)-T cell therapy has transformed the treatment of hematological malignancies, yet its broader application to solid tumors, chronic viral infections, and autoimmune diseases remains constrained by antigen heterogeneity, immunosuppressive tissue microenvironments, T-cell exhaustion, limited persistence, and treatment-associated toxicities. These challenges have shifted the field from optimizing individual receptor constructs toward engineering CAR-T cells as programmable immune systems capable of adapting to diverse disease contexts. This review synthesizes recent advances in molecular engineering strategies that enhance CAR-T cell function beyond conventional receptor design. We discuss how receptor engineering, genome editing, transcriptional and epigenetic regulation, metabolic reprogramming, synthetic gene circuits, and safety-control platforms collectively reshape CAR-T cell fate, persistence, and therapeutic efficacy. Rather than functioning independently, these engineering strategies are increasingly integrated to generate context-specific cellular therapies capable of adapting to diverse disease environments, including cancer, autoimmune diseases, and chronic viral infections. We also highlight the potential for translation into clinical practice or clinical translation and discuss the major challenges associated with clinical implementation. Next-generation CAR-T therapies will increasingly integrate molecular engineering strategies or will rely on molecular engineering strategies to integrate antigen recognition, cellular fitness, immune regulation, and longevity rather than simply maximizing cytotoxic activity. Recent advances in programmable cellular engineering coupled with rigorous clinical evaluation as well as scalable manufacturing technologies or scalable manufacturing platforms in the treatment of other diseases beyond oncology will facilitate the development of safer, more durable, and broadly applicable cellular therapies.
Digital health in clinical pharmacy practice: transforming precision medicine and pharmacometrics in Africa.
Alarfaj SJ, Wahsh E, Saad K, Sawan ES · Front Pharmacol (2026)
Egypt · DOI: 10.3389/fphar.2026.1924654
African nations still struggle with several healthcare challenges such as high prevalence of communicable and non-communicable diseases, underdeveloped healthcare systems, lack of healthcare personnel, and uneven distribution of quality healthcare services. Resource constraints and a fragmented healthcare system make the aforementioned challenges even more difficult to solve. However, digital health technology and artificial intelligence (AI) can be viewed as revolutionary instruments that may help to overcome the mentioned challenges and enhance healthcare practices in Africa. The present article provides a review of how digital health technologies and AI influence clinical pharmacy practice and contribute to precision medicine and pharmacometrics in African nations. To do that, a literature search has been performed using the PubMed, Scopus, and Web of Science electronic databases for relevant articles about digital health, AI, clinical pharmacy, precision medicine, pharmacometrics, and healthcare delivery in Africa. Healthcare technologies, such as telemedicine, mobile health apps, electronic health records, and clinical decision support systems powered by AI, are becoming more pervasive and widening the scope of work for clinical pharmacists through their contribution to medication optimization, therapeutic monitoring, and evidence-based clinical decision-making. Their application within precision medicine allows creating an individual treatment strategy considering the genetic and clinical features of the patients. At the same time, pharmacometric approaches, especially pharmacokinetics and pharmacodynamics modeling and model-informed precision dosing, help to optimize drug prescription and therapy outcomes for different African populations. The present article provides a review of how integrating digital health technologies and AI into clinical pharmacy practice could be a promising approach for enhancing precision medicine in Africa. The review also explores their implementation challenges and future opportunities for reasonable healthcare delivery.
Rhizobium zaerense sp. nov., a novel member of the Rhizobium leguminosarum species complex with a broad geographic distribution and multiple legume hosts.
Missbah El Idrissi M, Arraf SE, Lamin H, Lazar S, Mnasri B, Courty PE, Zouagui R · Int J Syst Evol Microbiol (2026)
Morocco · DOI: 10.1099/ijsem.0.007277
A novel nitrogen-fixing rhizobial strain, designated Z1P35ᵀ, was isolated from root nodules of Pisum sativum grown in the Zaër region of Morocco. Phylogenetic analysis of the 16S rRNA gene placed strain Z1P35ᵀ within the genus Rhizobium, showing 100% sequence identity with several undescribed genospecies of the Rhizobium leguminosarum species complex (Rlc). Strain Z1P35ᵀ exhibited low average nucleotide identity (ANI) and digital DNA-DNA hybridization (dDDH) values with all described Rhizobium species, but high ANI and dDDH values (97.62 and 78.8%, respectively) with Rhizobium sp. SRDI565, representing genospecies M (GsM) of the Rlc, suggesting that Z1P35ᵀ represents a novel species corresponding to GsM within this complex. FastANI screening against all Rhizobium genomes available in GenBank revealed that Z1P35ᵀ shares ANI values above the bacterial species delimitation threshold with 17 unclassified strains, which, together with Z1P35ᵀ and Rhizobium sp. SRDI565 (GsM), form a distinct lineage within the Rlc. These 17 strains originate from root nodules of diverse legume hosts and are distributed across the Mediterranean region and Australia, including representatives of the symbiovars viciae and trifolii. Phylogenomic analysis further confirms the clustering of Z1P35ᵀ with Rhizobium sp. SRDI565 (GsM) and several undescribed Rhizobium strains, forming a unique taxonomic unit clearly distinct from other members of the Rlc. Strain Z1P35ᵀ has a genome of 7.6 Mb with a G+C content of 61 mol% and carries numerous genes associated with chemotaxis, nodulation, nitrogen fixation, phosphate solubilization, iron acquisition and abiotic stress tolerance. Differentiation of Z1P35ᵀ from described Rhizobium species was further supported by phenotypic and chemotaxonomic analyses. Based on these results, we conclude that Z1P35T belongs to a novel species, corresponding to genospecies M within the Rlc, for which we propose the name Rhizobium zaerense sp. nov. The type strain is Z1P35ᵀ (DSM 120601ᵀ=CCMM B1365ᵀ).